|
|
|
|
Vol. 300, Issue 3, 1053-1062, March 2002
Departments of Drug Chemistry and Technology (F.S., R.F.) and
Clinical and Experimental Medicine (C.M., S.B., G.M., C.R.), University
of Perugia, Perugia, Italy; and Department of Experimental Medicine
(S.U., F.P.R., M.G.C.), University of L'Aquila, L'Aquila, Italy
1,4-Benzothiazine (1,4-B) derivatives exert numerous effects in vivo
and in vitro, including neurotoxicity and antitumor cytotoxicity. To
analyze the mechanisms responsible for 1,4-B-induced cytotoxicity, we
performed experiments to evaluate the possible apoptotic effect. For
that purpose, we used mouse thymocytes, a cell population well
sensitive to induction of apoptosis that has been used to assay
apoptosis in many experimental systems. Results indicate that a number
of 1,4-B analogs are able to induce both thymocyte apoptosis in vitro
and thymus cell loss in vivo. Moreover, analysis of the
structure-activity relationship indicate that the sulfur (S)
oxidation state, the presence of the carbonyl group, and the nature and
position of the side chain modulate the apoptotic efficacy. Moreover,
results of in vitro experiments show that the 1,4-B-induced apoptosis
associates with different biochemical events including phosphatidylcholine-specific phospholipase C activation, acidic sphingomyelinase activation and ceramide generation, loss of
mitochondrial membrane potential (
m) and cytochrome
c release, and caspase-8, -9, and -3 activation. These
results indicate that 1,4-B analogs induce apoptosis through a complex
of biochemical events.